Security
Nuwellis, Inc. Common Stock · NUWE
NUWENASDAQCommon stockCurrentCIK 1506492Updated Oct 27, 2026
Name history
CHF Solutions, Inc. · through Apr 16, 2021Sunshine Heart, Inc. · through May 23, 2017
NUWE price & chart
Loading TradingView…
NASDAQ:NUWE on TradingView ↗About the company
We are a commercial-stage medical technology company dedicated to transforming the lives of patients suffering from fluid overload through science, collaboration, and innovative technology. The Company is focused on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy, principally marketed as the Aquadex SmartFlow systems (collectively the “Aquadex System”). The Aquadex SmartFlow system is indicated for temporary (up to eight hours) or extended (longer than 8 hours in patients who require hospitalization) use in adult and pediatric patients weighing 20 kg or more whose fluid overload is unresponsive to medical management, including diuretics.
In the news
Incoming Nuwellis CEO Mike McCormick Underscores Strategic Priorities for Continued Market Expansion in Pediatric Category and Revenue Generation in Letter to Shareholders ↗
Recent filings
Material Modification to Rights of Security Holders · Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Items 3.03, 5.03, 9.01
EFFECT filing
424B3 filing
Regulation FD Disclosure
Items 7.01, 9.01
S-3 filing
Show 5 more recent filings
Financials
FY 2025 · USDSource
Source
Source
Source
Source
Source
balance sheet · annual statements
| Line item | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q2 2024 | Q1 2026 | Q1 2025 | Q1 2024 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| AssetsUSD | 7,984,000Source | 6,728,000Source | 9,126,000Source | 9,200,000Source | 6,189,000Source | 6,961,000Source | 7,006,000Source | 6,662,000Source | 6,118,000Source | 9,864,000Source | 9,770,000Source | 24,673,000Source |
| Property, Plant and Equipment, NetUSD | 414,000Source | 551,000Source | 347,000Source | 359,000Source | 630,000Source | 365,000Source | 405,000Source | 681,000Source | 368,000Source | 478,000Source | 728,000Source | 980,000Source |
| Current assets: | ||||||||||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 3,094,000Source | 1,907,000Source | 3,922,000Source | 4,450,000Source | 1,023,000Source | 2,083,000Source | 2,557,000Source | 1,400,000Source | 1,085,000Source | 5,095,000Source | 3,800,000Source | 17,737,000Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 1,141,000Source | 1,293,000Source | 1,545,000Source | 1,193,000Source | 1,292,000Source | 1,559,000Source | 1,540,000Source | 1,226,000Source | 1,493,000Source | 1,727,000Source | 1,951,000Source | 1,406,000Source |
| Inventory, NetUSD | 2,189,000Source | 1,864,000Source | 1,742,000Source | 2,028,000Source | 1,967,000Source | 1,779,000Source | 1,752,000Source | 2,131,000Source | 1,910,000Source | 1,718,000Source | 1,997,000Source | 2,661,000Source |
| Assets, CurrentUSD | 7,200,000Source | 5,494,000Source | 7,899,000Source | 8,416,000Source | 4,826,000Source | 5,827,000Source | 6,123,000Source | 5,197,000Source | 5,186,000Source | 8,855,000Source | 8,209,000Source | 22,769,000Source |
| Operating Lease, Right-of-Use AssetUSD | 349,000Source | 563,000Source | 179,000Source | 404,000Source | 613,000Source | 237,000Source | 457,000Source | 664,000Source | 293,000Source | 510,000Source | 713,000Source | 903,000Source |
| Other Assets, NoncurrentUSD | 21,000Source | 120,000Source | 599,000Source | 21,000Source | 120,000Source | 420,000Source | 21,000Source | 120,000Source | 271,000Source | 21,000Source | 120,000Source | 21,000Source |
| LIABILITIES AND EQUITY | ||||||||||||
| LiabilitiesUSD | 4,070,000Source | 3,549,000Source | 11,171,000Source | 18,155,000Source | 13,023,000Source | 4,292,000Source | 3,424,000Source | 5,775,000Source | 3,488,000Source | 3,334,000Source | 6,559,000Source | 12,316,000Source |
| Stockholders’ equity: | ||||||||||||
| Preferred Stock, Value, IssuedUSD | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source |
| Common Stock, Value, IssuedUSD | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 1,000Source | 0Source | 0Source | 1,000Source | 0Source |
| Additional Paid in CapitalUSD | 317,852,000Source | 300,546,000Source | 323,618,000Source | 305,452,000Source | 292,887,000Source | 323,506,000Source | 305,432,000Source | 292,880,000Source | 318,928,000Source | 305,366,000Source | 290,646,000Source | 279,736,000Source |
| Retained Earnings (Accumulated Deficit)USD | -313,890,000Source | -297,323,000Source | -325,681,000Source | -314,358,000Source | -299,681,000Source | -320,853,000Source | -301,805,000Source | -291,956,000Source | -316,312,000Source | -298,791,000Source | -287,626,000Source | -267,417,000Source |
| Stockholders' Equity Attributable to ParentUSD | 3,908,000Source | 3,177,000Source | -2,055,000Source | -8,960,000Source | -6,836,000Source | 2,661,000Source | 3,578,000Source | 885,000Source | 2,624,000Source | 6,528,000Source | 2,990,000Source | 12,357,000Source |
| Liabilities and EquityUSD | 7,984,000Source | 6,728,000Source | 9,126,000Source | 9,200,000Source | 6,189,000Source | 6,961,000Source | 7,006,000Source | 6,662,000Source | 6,118,000Source | 9,864,000Source | 9,770,000Source | 24,673,000Source |
| Current liabilities: | ||||||||||||
| Liabilities, CurrentUSD | 3,522,000Source | 2,701,000Source | 4,008,000Source | 3,892,000Source | 4,016,000Source | 3,730,000Source | 2,749,000Source | 4,323,000Source | 3,032,000Source | 2,559,000Source | 3,172,000Source | 4,688,000Source |
| Operating Lease, Liability, CurrentUSD | 255,000Source | 232,000Source | 200,000Source | 249,000Source | 226,000Source | 265,000Source | 243,000Source | 221,000Source | 261,000Source | 238,000Source | 216,000Source | 196,000Source |
| Operating Lease, Liability, NoncurrentUSD | 128,000Source | 368,000Source | 0Source | 189,000Source | 428,000Source | 0Source | 249,000Source | 488,000Source | 67,000Source | 307,000Source | 544,000Source | 760,000Source |
| Other Liabilities, NoncurrentUSD | — | — | — | — | — | — | — | — | — | — | — | 0Source |
| Additional Financial Items | ||||||||||||
| AOCI, Debt Securities, Available-for-sale, Adjustment, after TaxUSD | — | — | — | — | — | — | — | — | — | — | 0Source | 56,000Source |
cash flow · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Depreciation, Depletion and AmortizationUSD | — | — | — | — | — | — | 38,000Source | 73,000Source | 200,000Source | 310,000Source | 362,000Source | 372,000Source |
| Share-based Payment Arrangement, Noncash ExpenseUSD | — | — | — | — | — | — | 25,000Source | 67,000Source | 127,000Source | 478,000Source | 670,000Source | 862,000Source |
| Changes in operating assets and liabilities: | ||||||||||||
| Increase (Decrease) in Accounts ReceivableUSD | — | — | — | — | — | — | 66,000Source | -187,000Source | -234,000Source | -224,000Source | 545,000Source | 656,000Source |
| Increase (Decrease) in InventoriesUSD | — | — | — | — | — | — | -181,000Source | 34,000Source | 192,000Source | -279,000Source | -697,000Source | -140,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | — | — | — | — | — | — | -3,112,000Source | -2,536,000Source | -10,810,000Source | -9,591,000Source | -17,937,000Source | -15,149,000Source |
| Cash flows from investing activities: | ||||||||||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | — | — | — | — | — | — | -284,000Source | 0Source | -90,000Source | -60,000Source | 330,000Source | 14,728,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | — | — | — | — | — | — | 30,000Source | 0Source | 90,000Source | 60,000Source | 149,000Source | 122,000Source |
| Cash flows from financing activities: | ||||||||||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | — | — | — | — | — | — | 4,395,000Source | 0Source | 6,940,000Source | 10,962,000Source | 3,683,000Source | 9,423,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | — | — | — | — | — | — | 999,000Source | -2,538,000Source | -3,905,000Source | 1,295,000Source | -13,937,000Source | 8,995,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | — | 3,094,000Source | 1,907,000Source | 4,028,000Source | 4,450,000Source | 2,189,000Source | 2,557,000Source | 1,190,000Source | 5,095,000Source | 3,800,000Source | 17,737,000Source |
| Supplemental disclosure of cash flow information: | ||||||||||||
| Income Taxes Paid, NetUSD | — | — | — | — | — | — | — | — | 7,000Source | 7,000Source | 12,000Source | 9,000Source |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | — | — | — | — | — | 0Source | -2,000Source | 55,000Source | -16,000Source | -13,000Source | -7,000Source |
| Additional Financial Items | ||||||||||||
| Share-based Payment Arrangement, ExpenseUSD | — | — | 18,000Source | 101,000Source | 22,000Source | 17,000Source | 25,000Source | 67,000Source | 127,000Source | 478,000Source | 670,000Source | 862,000Source |
| Amortization of Debt Issuance CostsUSD | — | — | 0Source | 0Source | 6,077,000Source | 10,553,000Source | — | — | 10,553,000Source | 5,607,000Source | 3,483,000Source | 9,247,000Source |
| DepreciationUSD | — | — | — | — | — | — | — | — | 200,000Source | — | — | 372,000Source |
| Gain (Loss) on Disposition of Intangible AssetsUSD | — | — | — | — | — | — | — | — | 0Source | -99,000Source | — | — |
| Income Tax Expense (Benefit)USD | — | — | 0Source | 0Source | 0Source | 4,000Source | 0Source | 1,000Source | 5,000Source | 5,000Source | 8,000Source | 9,000Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | 468,000Source | 2,358,000Source | -4,828,000Source | -12,553,000Source | -4,541,000Source | -3,014,000Source | -17,521,000Source | -11,165,000Source | -20,209,000Source | -14,525,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | — | 469,000Source | 2,358,000Source | -4,827,000Source | -12,552,000Source | -4,539,000Source | -3,013,000Source | -17,517,000Source | -10,624,000Source | -22,627,000Source | -14,525,000Source |
| Operating ExpensesUSD | — | — | 4,142,000Source | 3,188,000Source | 4,667,000Source | 3,864,000Source | 6,252,000Source | 4,127,000Source | 16,230,000Source | 16,664,000Source | 22,613,000Source | 21,926,000Source |
| Other Nonoperating Income (Expense)USD | — | — | 4,000Source | 8,000Source | 7,000Source | 10,000Source | 1,000Source | 7,000Source | 10,000Source | -80,000Source | — | 75,000Source |
| Proceeds from Issuance of Common StockUSD | — | — | — | — | — | — | 4,393,000Source | 0Source | 3,999,000Source | — | — | — |
| Payments to Acquire Businesses, Net of Cash Acquired | — | — | — | — | — | — | —Source | —Source | — | — | — | — |
income statement · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total RevenueUSD | — | — | 2,217,000Source | 2,367,000Source | 1,969,000Source | 1,725,000Source | 2,403,000Source | 1,904,000Source | 8,270,000Source | 8,740,000Source | 8,864,000Source | 8,543,000Source |
| Cost of RevenueUSD | — | — | 772,000Source | 711,000Source | 471,000Source | 767,000Source | 719,000Source | 837,000Source | 3,146,000Source | 3,064,000Source | 3,881,000Source | 3,788,000Source |
| Selling, General and Administrative ExpenseUSD | — | — | 3,539,000Source | 2,702,000Source | 3,725,000Source | 3,189,000Source | 4,524,000Source | 3,577,000Source | 13,518,000Source | 13,455,000Source | 17,191,000Source | 17,584,000Source |
| Operating Income (Loss)USD | — | — | -2,697,000Source | -1,532,000Source | -3,169,000Source | -2,906,000Source | -4,568,000Source | -3,060,000Source | -11,106,000Source | -10,988,000Source | -17,630,000Source | -17,171,000Source |
| Other Nonoperating Income (Expense)USD | — | — | 4,000Source | 8,000Source | 7,000Source | 10,000Source | 1,000Source | 7,000Source | 10,000Source | -80,000Source | — | 75,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | — | — | 468,000Source | 2,358,000Source | -4,828,000Source | -12,549,000Source | -4,541,000Source | -3,013,000Source | -17,516,000Source | -11,160,000Source | -20,201,000Source | -14,516,000Source |
| Income Tax Expense (Benefit)USD | — | — | 0Source | 0Source | 0Source | 4,000Source | 0Source | 1,000Source | 5,000Source | 5,000Source | 8,000Source | 9,000Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | 468,000Source | 2,358,000Source | -4,828,000Source | -12,553,000Source | -4,541,000Source | -3,014,000Source | -17,521,000Source | -11,165,000Source | -20,209,000Source | -14,525,000Source |
| Earnings Per Share, BasicUSD per share | — | — | — | — | -26.64Source | -2,134.19Source | — | — | -25.39Source | -8.41Source | -11.52Source | -83.55Source |
| Earnings Per Share, DilutedUSD per share | — | — | — | — | -26.64Source | -2,134.19Source | — | — | -25.39Source | -8.41Source | -11.52Source | -83.55Source |
| Weighted Average Number of Shares Outstanding, Basicshares | — | — | — | — | 181,243Source | 5,881Source | — | — | 690,145Source | 1,327,252Source | 1,964,406Source | 174,000Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | — | — | — | — | 181,243Source | 5,881Source | — | — | 690,145Source | 1,327,252Source | 1,964,406Source | 174,000Source |
| Additional Financial Items | ||||||||||||
| Depreciation, Depletion and Amortization, NonproductionUSD | — | — | — | — | — | — | 38,000Source | 73,000Source | 200,000Source | 310,000Source | 362,000Source | — |
| Gross ProfitUSD | — | — | 1,445,000Source | 1,656,000Source | 1,498,000Source | 958,000Source | 1,684,000Source | 1,067,000Source | 5,124,000Source | 5,676,000Source | 4,983,000Source | 4,755,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD | — | — | — | — | — | — | — | — | -17,540,000Source | -11,190,000Source | -20,233,000Source | -14,551,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | — | 469,000Source | 2,358,000Source | -4,827,000Source | -12,552,000Source | -4,539,000Source | -3,013,000Source | -17,517,000Source | -10,624,000Source | -22,627,000Source | -14,525,000Source |
| Operating ExpensesUSD | — | — | 4,142,000Source | 3,188,000Source | 4,667,000Source | 3,864,000Source | 6,252,000Source | 4,127,000Source | 16,230,000Source | 16,664,000Source | 22,613,000Source | 21,926,000Source |
| Preferred Stock Dividends and Other AdjustmentsUSD | — | — | -1,000Source | 0Source | -1,000Source | -1,000Source | -2,000Source | -1,000Source | -4,000Source | -541,000Source | 2,297,000Source | 0Source |
| Preferred Stock Dividends, Income Statement ImpactUSD | — | — | — | — | — | — | — | — | — | 0Source | 121,000Source | — |
| Research and Development ExpenseUSD | — | — | 603,000Source | 486,000Source | 942,000Source | 675,000Source | 1,728,000Source | 550,000Source | 2,712,000Source | 3,209,000Source | 5,422,000Source | 4,342,000Source |
Offerings
Registration 333-298422
Registration 333-296198
- Gross proceeds
- 6000000.0
- Net proceeds
- 5460000.0
- Deal price
- 0.3
- Shares
- 20000000
- Offering price
- $0.30
- Ticker
- NUWE
Underwriters: Ladenburg Thalmann & Co. Inc.
Registration 333-296518
Registration 333-293181
Registration 333-287663
- Gross proceeds
- 4346417.0
- Net proceeds
- 3955113.0
- Deal price
- 0.3
- Shares
- 14488057
- Offering price
- $0.30
- Ticker
- NUWE
Filing attachments
ef20081099_ex99-1.htm · 8-K · 2026-08-26
EX-99.1 2 ef20081099_ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 August 2026 INVESTOR PRESENTATION NASDQ: NUWE Forward-Looking Statements This presentation contains forward‐looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities and Exchange Act, as amended regarding our plans, expectations, beliefs, estimates, goals and outlook for the future that are intended to be covered by the Private Securities Litigation Reform Act of…
Read attachment ↗ny20080465x1_ex107.htm · S-3 · 2026-08-18
Exhibit 107 CALCULATION OF FILING FEE TABLE FORM S-3 (Form Type) NUWELLIS, INC. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation or Carry Forward Rule Amount Registered(1) Proposed Maximum Offering Price Per Unit Maximum Aggregate Fee Rate Amount of Registration Fee …
Read attachment ↗ef20080204_ex99-1.htm · 8-K · 2026-08-13
EX-99.1 2 ef20080204_ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 FOR IMMEDIATE RELEASE August 13, 2026 Nuwellis Reports Second Quarter 2026 Financial Results and Business Highlights Focused on Double Digit Revenue Growth and Expanded Gross Margin Recent capital raise and warrant exercises extend cash runway through second quarter of 2027 Conference call begins at 9:00 a.m. Eastern time today MINNEAPOLIS - August 13, 2026 - Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company committed …
Read attachment ↗ef20079229_ex4-1.htm · 8-K · 2026-08-03
EX-4.1 2 ef20079229_ex4-1.htm EXHIBIT 4.1 Exhibit 4.1 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT …
Read attachment ↗ef20079229_ex4-2.htm · 8-K · 2026-08-03
EX-4.2 3 ef20079229_ex4-2.htm EXHIBIT 4.2 Exhibit 4.2 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT …
Read attachment ↗ef20079229_ex99-1.htm · 8-K · 2026-08-03
EX-99.1 7 ef20079229_ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 Nuwellis Announces Pricing of $3.4 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules Nuwellis also received $3.1 Million from the Exercise of Previously Issued Warrants from the June 2026 Public Offering MINNEAPOLIS, July 31, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE) (“Nuwellis” or the “Company”), a medical technology company committed to delivering solutions for patients with cardiorenal cond…
Read attachment ↗